Drug Discovery, Biotech, and AI with Alex Zhavoronkov, CEO, Insilico Medicine (CXOTalk #327)
Artificial intelligence offers the promise of better health, faster drug discovery and testing, to create improved medical outcomes for patients. We talk with a world expert on using AI in life sciences to discover and develop drugs faster and less expensively. AI and machine learning help select therapy candidates and assist with clinical trials.
Read the complete transcript: https://www.cxotalk.com/episode/ai-medicine-life-sciences-drug-discovery
Dr. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a leader in the next-generation artificial intelligence for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI. Since 2012 he published over 130 peer-reviewed research papers and 2 books. For six years in a row, he has organized the annual Aging Research for Drug Discovery and Artificial Intelligence for Healthcare forums at Basel Life/EMBO in Basel. Alex is an adjunct professor at the Buck Institute for Research on Aging.
Видео Drug Discovery, Biotech, and AI with Alex Zhavoronkov, CEO, Insilico Medicine (CXOTalk #327) канала CXOTALK
Read the complete transcript: https://www.cxotalk.com/episode/ai-medicine-life-sciences-drug-discovery
Dr. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a leader in the next-generation artificial intelligence for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI. Since 2012 he published over 130 peer-reviewed research papers and 2 books. For six years in a row, he has organized the annual Aging Research for Drug Discovery and Artificial Intelligence for Healthcare forums at Basel Life/EMBO in Basel. Alex is an adjunct professor at the Buck Institute for Research on Aging.
Видео Drug Discovery, Biotech, and AI with Alex Zhavoronkov, CEO, Insilico Medicine (CXOTalk #327) канала CXOTALK
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
President Clinton speaks with Elizabeth Holmes and Jack Ma (2015 CGI Annual Meeting)Michelle Gill - Artificial Intelligence Driven Drug DiscoveryManaging Teams for Data Science, Analytics, and AI (CXOTalk # 326)Artificial Intelligence-based Biomarkers of Ageing | Dr Alex ZhavoronkovWorkday CEO Aneel Bhusri: Machine Learning and Corporate Culture (CxOTalk #359)Biotechnology/Nanotechnology | Andrew Hessel | SingularityU Germany Summit 2017#208: Digital Transformation and Leadership: Executive Guide for the CIO and Chief Digital OfficerDesigning Drugs With Machine Learning - Fabian Pitter Steinmetz (Merck KGaA)In silico medicine will be the futureWill Self-Taught, A.I. Powered Robots Be the End of Us?Future of Telecomm with 5G and IoT - Vodafone (CXOTalk interview #310)Using Big Data to Improve Healthcare Services | Tiranee Achalakul | TEDxChiangMaiWill Artificial Intelligence Revolutionize Pharma?Artificial Intelligence and Machine Learning in Medicine: Hope or Hype?Data Science in Drug Discovery | Wrangle ConferenceData Science, Predictive Analytics, and AI in Drug Discovery with Novartis (CXOTalk #717)Better Medicine Through Machine Learning | Suchi Saria | TEDxBostonStem Cells In Chronic Diseases | Roberta Shapiro | TEDxBeaconStreetWhat is a Chief Marketing Officer? With Deloitte CMO and CVS Health CMO (CXOTalk #712)MIT Quest for Intelligence Launch: AI-Driven Drug Discovery